Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.

Additionally, after the FDA approved Wegovy (Semaglutide) for treating heart disease, including for those with obesity or overweight, Medicare plans may be able to cover it for those who require ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

An analysis of differential coding patterns between Medicare Advantage (MA) and Traditional Medicare (TM) plans estimated how much coding differs between insurers and how much extra revenue insurers ...